ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 106969 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 106969; 2) Community: the network communities that were significantly associated with the response to NSC 106969; 3) Molecule: the relationships between components within communities and NSC 106969; 4) MDR: the compounds that were significantly associated with the NSC 106969.

NSC Compound Enrichment Correlation
NSC 717953 Null 0.0186186224062458 0.14183712
NSC 718781 Erlotinib hydrochloride 0.0186186224062458 -0.062351312
NSC 719667 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one 0.0186186224062458 0.16674107
NSC 720134 Null 0.0186186224062458 -0.050631269
NSC 726578 Null 0.0186186224062458 0.19287185
NSC 729166 N,N'-didecyl 4,4'-(1,4-piperazinediyl)bisbenzenecarboximidamide 0.0186186224062458 0.16562365
NSC 734949 4-[3-(3,4-dihydro-1H-isoquinolin-2-yl)prop-1-en-2-yl]-N-pyrazin-2-ylbenzamide 0.0186186224062458 0.32928133
NSC 743532 Null 0.0186186224062458 -0.1260078
NSC 748147 5-methyl-2-{[(2)-3-phenylprop-2-enoyl]amino}benzamide 0.0186186224062458 0.56364747
NSC 751605 (E)-N-[4-(1-benzoylpiperidine-4-yl)butyl]-3-(pyridin-3-yl)acrylamide 0.0186186224062458 0.36039452
Total:95  Current:48    [First] [Prev] [Next] [Last]